{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:47:58Z","timestamp":1790365678499,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Bundesministerium f\u00fcr Bildung und Forschung, Stiftung Zukunfts- und Innovationsfonds Niedersachsen and Helmholtz-Zentrum f\u00fcr Infektionsforschung","award":["IG-SCID-TwinPro02"],"award-info":[{"award-number":["IG-SCID-TwinPro02"]}]},{"name":"Indian Council of Medical Research (India) - HGF (Helmholtz Association, Germany)","award":["5\/8\/7\/9\/2007(A)-ECD-I"],"award-info":[{"award-number":["5\/8\/7\/9\/2007(A)-ECD-I"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12985-016-0507-5","type":"journal-article","created":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T12:42:13Z","timestamp":1460983333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype"],"prefix":"10.1186","volume":"13","author":[{"given":"Suvercha","family":"Bhardwaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fareed","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Cornberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Schulze zur Wiesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"van Lunzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv K.","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold E.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Meyer-Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,18]]},"reference":[{"issue":"3","key":"507_CR1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","volume":"112","author":"MA Caligiuri","year":"2008","unstructured":"Caligiuri MA. Human natural killer cells. Blood. 2008;112(3):461\u20139.","journal-title":"Blood"},{"issue":"6013","key":"507_CR2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","volume":"331","author":"E Vivier","year":"2011","unstructured":"Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science. 2011;331(6013):44\u20139.","journal-title":"Science"},{"issue":"11","key":"507_CR3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nri1711","volume":"5","author":"AS Fauci","year":"2005","unstructured":"Fauci AS, Mavilio D, Kottilil S. NK cells in HIV infection: paradigm for protection or targets for ambush. Nat Rev Immunol. 2005;5(11):835\u201343.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"507_CR4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli A, Michel T, Theresine M, Andres E, Hentges F, Zimmer J. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology. 2009;126(4):458\u201365.","journal-title":"Immunology"},{"issue":"11","key":"507_CR5","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.166.11.6477","volume":"166","author":"JJ Campbell","year":"2001","unstructured":"Campbell JJ, Qin S, Unutmaz D, Soler D, Murphy KE, Hodge MR, et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol. 2001;166(11):6477\u201382.","journal-title":"J Immunol"},{"issue":"11","key":"507_CR6","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1182\/blood-2009-08-238469","volume":"115","author":"C Fauriat","year":"2010","unstructured":"Fauriat C, Long EO, Ljunggren HG, Bryceson YT. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood. 2010;115(11):2167\u201376.","journal-title":"Blood"},{"issue":"10","key":"507_CR7","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","volume":"97","author":"MA Cooper","year":"2001","unstructured":"Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood. 2001;97(10):3146\u201351.","journal-title":"Blood"},{"issue":"4","key":"507_CR8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/gut.51.4.601","volume":"51","author":"AH Mohsen","year":"2002","unstructured":"Mohsen AH, Easterbrook P, Taylor CB, Norris S. Hepatitis C and HIV-1 coinfection. Gut. 2002;51(4):601\u20138.","journal-title":"Gut"},{"issue":"11","key":"507_CR9","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.4049\/jimmunol.168.11.5764","volume":"168","author":"L Azzoni","year":"2002","unstructured":"Azzoni L, Papasavvas E, Chehimi J, Kostman JR, Mounzer K, Ondercin J, et al. Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity. J Immunol. 2002;168(11):5764\u201370.","journal-title":"J Immunol"},{"issue":"2","key":"507_CR10","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1128\/JVI.01675-09","volume":"84","author":"HS Hong","year":"2010","unstructured":"Hong HS, Eberhard JM, Keudel P, Bollmann BA, Ballmaier M, Bhatnagar N, et al. HIV infection is associated with a preferential decline in less-differentiated CD56dim CD16+ NK cells. J Virol. 2010;84(2):1183\u20138.","journal-title":"J Virol"},{"issue":"3","key":"507_CR11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/hep.25723","volume":"56","author":"S Varchetta","year":"2012","unstructured":"Varchetta S, Mele D, Mantovani S, Oliviero B, Cremonesi E, Ludovisi S, et al. Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection. Hepatology. 2012;56(3):841\u20139.","journal-title":"Hepatology"},{"issue":"4","key":"507_CR12","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2011.06.069","volume":"141","author":"G Ahlenstiel","year":"2011","unstructured":"Ahlenstiel G, Edlich B, Hogdal LJ, Rotman Y, Noureddin M, Feld JJ, et al. Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. Gastroenterology. 2011;141(4):1231\u20139. 9 e1-2.","journal-title":"Gastroenterology"},{"issue":"21","key":"507_CR13","doi-asserted-by":"crossref","first-page":"12397","DOI":"10.1128\/JVI.01420-14","volume":"88","author":"F Ahmad","year":"2014","unstructured":"Ahmad F, Hong HS, Jackel M, Jablonka A, Lu IN, Bhatnagar N, et al. High frequencies of polyfunctional CD8+ NK cells in chronic HIV-1 infection are associated with slower disease progression. J Virol. 2014;88(21):12397\u2013408.","journal-title":"J Virol"},{"issue":"9","key":"507_CR14","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/eji.200324141","volume":"33","author":"A Maria De","year":"2003","unstructured":"De Maria A, Fogli M, Costa P, Murdaca G, Puppo F, Mavilio D, et al. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol. 2003;33(9):2410\u20138.","journal-title":"Eur J Immunol"},{"issue":"2","key":"507_CR15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2567.2009.03171.x","volume":"129","author":"P Mantegani","year":"2010","unstructured":"Mantegani P, Tambussi G, Galli L, Din CT, Lazzarin A, Fortis C. Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset. Immunology. 2010;129(2):220\u201333.","journal-title":"Immunology"},{"issue":"2","key":"507_CR16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/eji.200635989","volume":"37","author":"A Maria De","year":"2007","unstructured":"De Maria A, Fogli M, Mazza S, Basso M, Picciotto A, Costa P, et al. Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur J Immunol. 2007;37(2):445\u201355.","journal-title":"Eur J Immunol"},{"issue":"6","key":"507_CR17","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1182\/blood-2005-04-1636","volume":"107","author":"D Meyer-Olson","year":"2006","unstructured":"Meyer-Olson D, Brady KW, Bartman MT, O\u2019Sullivan KM, Simons BC, Conrad JA, et al. Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire. Blood. 2006;107(6):2373\u201383.","journal-title":"Blood"},{"issue":"6","key":"507_CR18","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.4049\/jimmunol.1300164","volume":"191","author":"KA Holder","year":"2013","unstructured":"Holder KA, Stapleton SN, Gallant ME, Russell RS, Grant MD. Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions. J Immunol. 2013;191(6):3308\u201318.","journal-title":"J Immunol"},{"issue":"2","key":"507_CR19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/imm.12495","volume":"146","author":"S Mantovani","year":"2015","unstructured":"Mantovani S, Mele D, Oliviero B, Barbarini G, Varchetta S, Mondelli MU. NKp30 isoforms in patients with chronic hepatitis C virus infection. Immunology. 2015;146(2):234\u201342.","journal-title":"Immunology"},{"issue":"5428","key":"507_CR20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","volume":"285","author":"S Bauer","year":"1999","unstructured":"Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999;285(5428):727\u20139.","journal-title":"Science"},{"issue":"1","key":"507_CR21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.gastro.2009.08.066","volume":"138","author":"G Ahlenstiel","year":"2010","unstructured":"Ahlenstiel G, Titerence RH, Koh C, Edlich B, Feld JJ, Rotman Y, et al. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology. 2010;138(1):325\u201335. e1-2.","journal-title":"Gastroenterology"},{"issue":"2","key":"507_CR22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1078\/0171-2985-00219","volume":"207","author":"J Clausen","year":"2003","unstructured":"Clausen J, Vergeiner B, Enk M, Petzer AL, Gastl G, Gunsilius E. Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells. Immunobiology. 2003;207(2):85\u201393.","journal-title":"Immunobiology"},{"issue":"8","key":"507_CR23","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","volume":"77","author":"EJ Wherry","year":"2003","unstructured":"Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol. 2003;77(8):4911\u201327.","journal-title":"J Virol"},{"issue":"3","key":"507_CR24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/318501","volume":"32","author":"I Bica","year":"2001","unstructured":"Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;32(3):492\u20137.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"507_CR25","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2007.130963","volume":"57","author":"L Golden-Mason","year":"2008","unstructured":"Golden-Mason L, Madrigal-Estebas L, McGrath E, Conroy MJ, Ryan EJ, Hegarty JE, et al. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut. 2008;57(8):1121\u20138.","journal-title":"Gut"},{"issue":"4","key":"507_CR26","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jmv.21742","volume":"82","author":"S Lee","year":"2010","unstructured":"Lee S, Watson MW, Flexman JP, Cheng W, Hammond T, Price P. Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alpha and ribavirin therapy. J Med Virol. 2010;82(4):568\u201374.","journal-title":"J Med Virol"},{"issue":"8","key":"507_CR27","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00535-011-0408-8","volume":"46","author":"T Miyagi","year":"2011","unstructured":"Miyagi T, Shimizu S, Tatsumi T, Nishio K, Hiramatsu N, Kanto T, et al. Differential alteration of CD56(bright) and CD56 (dim) natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection. J Gastroenterol. 2011;46(8):1020\u201330.","journal-title":"J Gastroenterol"},{"issue":"1","key":"507_CR28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-3083.2008.02116.x","volume":"68","author":"W Barcelos","year":"2008","unstructured":"Barcelos W, Sathler-Avelar R, Martins-Filho OA, Carvalho BN, Guimaraes TM, Miranda SS, et al. Natural killer cell subpopulations in putative resistant individuals and patients with active Mycobacterium tuberculosis infection. Scand J Immunol. 2008;68(1):92\u2013102.","journal-title":"Scand J Immunol"},{"issue":"9","key":"507_CR29","doi-asserted-by":"crossref","first-page":"e44820","DOI":"10.1371\/journal.pone.0044820","volume":"7","author":"HS Hong","year":"2012","unstructured":"Hong HS, Ahmad F, Eberhard JM, Bhatnagar N, Bollmann BA, Keudel P, et al. Loss of CCR7 expression on CD56(bright) NK cells is associated with a CD56(dim)CD16(+) NK cell-like phenotype and correlates with HIV viral load. PLoS One. 2012;7(9):e44820.","journal-title":"PLoS One"},{"key":"507_CR30","doi-asserted-by":"crossref","first-page":"152430","DOI":"10.1155\/2011\/152430","volume":"2011","author":"F Marras","year":"2011","unstructured":"Marras F, Bozzano F, De Maria A. Involvement of activating NK cell receptors and their modulation in pathogen immunity. J Biomed Biotechnol. 2011;2011:152430.","journal-title":"J Biomed Biotechnol"},{"issue":"12","key":"507_CR31","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","volume":"12","author":"JM Brenchley","year":"2006","unstructured":"Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12(12):1365\u201371.","journal-title":"Nat Med"},{"key":"507_CR32","doi-asserted-by":"crossref","unstructured":"Ahmad F, Tufa DM, Mishra N, Jacobs R, Schmidt RE. Terminal differentiation of CD56dimCD16+ natural killer cells is associated with increase in natural killer cell frequencies after antiretroviral treatment in HIV-1 infection. AIDS Res Hum Retroviruses. 2015;31(12):1206\u201312.","DOI":"10.1089\/aid.2015.0115"},{"key":"507_CR33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-4690-6-91","volume":"6","author":"B Poonia","year":"2009","unstructured":"Poonia B, Pauza CD, Salvato MS. Role of the Fas\/FasL pathway in HIV or SIV disease. Retrovirology. 2009;6:91.","journal-title":"Retrovirology"},{"issue":"2","key":"507_CR34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/QAI.0b013e3180dc9909","volume":"46","author":"S Kottilil","year":"2007","unstructured":"Kottilil S, Jackson JO, Reitano KN, O\u2019Shea MA, Roby G, Lloyd M, et al. Innate immunity in HIV infection: enhanced susceptibility to CD95-mediated natural killer cell death and turnover induced by HIV viremia. J Acquir Immune Defic Syndr. 2007;46(2):151\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"507_CR35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00126334-200001010-00006","volume":"23","author":"JC Wasmuth","year":"2000","unstructured":"Wasmuth JC, Klein KH, Hackbarth F, Rockstroh JK, Sauerbruch T, Spengler U. Prediction of imminent complications in HIV-1-infected patients by markers of lymphocyte apoptosis. J Acquir Immune Defic Syndr. 2000;23(1):44\u201351.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"507_CR36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1067\/mai.2001.117791","volume":"108","author":"A Vigano","year":"2001","unstructured":"Vigano A, Pinti M, Nasi M, Moretti L, Balli F, Mussini C, et al. Markers of cell death-activation in lymphocytes of vertically HIV-infected children naive to highly active antiretroviral therapy: the role of age. J Allergy Clin Immunol. 2001;108(3):439\u201345.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"507_CR37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/01.qai.0000223027.47456.d0","volume":"42","author":"SW Read","year":"2006","unstructured":"Read SW, Higgins J, Metcalf JA, Stevens RA, Rupert A, Nason MC, et al. Decreased CD127 expression on T Cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapy. J Acquir Immune Defic Syndr. 2006;42(5):537\u201344.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"507_CR38","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4103\/0971-5916.92645","volume":"134","author":"K Mojumdar","year":"2011","unstructured":"Mojumdar K, Vajpayee M, Chauhan NK, Singh A, Singh R, Kurapati S. Loss of CD127 & increased immunosenescence of T cell subsets in HIV infected individuals. Indian J Med Res. 2011;134(6):972\u201381.","journal-title":"Indian J Med Res"},{"issue":"47","key":"507_CR39","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.3748\/wjg.14.7149","volume":"14","author":"JR Larrubia","year":"2008","unstructured":"Larrubia JR, Benito-Martinez S, Calvino M, Sanz-de-Villalobos E, Parra-Cid T. Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J Gastroenterol. 2008;14(47):7149\u201359.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"507_CR40","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2893.2006.00838.x","volume":"14","author":"M Zeremski","year":"2007","unstructured":"Zeremski M, Petrovic LM, Talal AH. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepat. 2007;14(10):675\u201387.","journal-title":"J Viral Hepat"},{"issue":"6","key":"507_CR41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/vim.2011.0035","volume":"24","author":"P Kimball","year":"2011","unstructured":"Kimball P, McDougan F, Stirling R. CXCR3 expression elevated on peripheral CD8(+) lymphocytes from HIV\/HCV coinfected individuals. Viral Immunol. 2011;24(6):441\u20138.","journal-title":"Viral Immunol"},{"issue":"7","key":"507_CR42","doi-asserted-by":"crossref","first-page":"e38846","DOI":"10.1371\/journal.pone.0038846","volume":"7","author":"M Eisenhardt","year":"2012","unstructured":"Eisenhardt M, Glassner A, Kramer B, Korner C, Sibbing B, Kokordelis P, et al. The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C. PLoS One. 2012;7(7):e38846.","journal-title":"PLoS One"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-016-0507-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T20:40:40Z","timestamp":1718484040000},"score":1,"resource":{"primary":{"URL":"http:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-016-0507-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,18]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["507"],"URL":"https:\/\/doi.org\/10.1186\/s12985-016-0507-5","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,18]]},"article-number":"67"}}